Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs
✍ Scribed by Jiřina Hofmanová; Alena Vaculová; Zuzana Koubková; Martina Hýžd'alová; Alois Kozubík
- Book ID
- 102948175
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 974 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We verified the hypothesis suggesting modulation of the effects of sodium butyrate (NaBt) by ω–3 or ω–6 PUFAs. Comparing the response of human colon epithelial cell lines of fetal (FHC) and adenocarcinoma (HT‐29, HCT‐116) origin, we detected significant differences in proliferation, differentiation and apoptotic response to the treatment of NaBt, arachidonic or docosahexaenoic acids and their combination. While in FHC and HT‐29 cells NaBt induced G0/G1 arrest, differentiation and low level of apoptosis, in HCT‐116 cells G2/M arrest, no differentiation and high degree of apoptosis were detected. Moreover, in FHC cells significant potentiation of apoptosis accompanied by increased arrest in the cell cycle, cell detachment and decrease in differentiation were detected after combined treatment with NaBt and both PUFAs. Changes in cytokinetics induced by fatty acids were accompanied by membrane lipid unpacking, reactive oxygen species (ROS) production, and decrease in mitochondrial membrane potential (MMP). Detection of caspase‐3 activation and dynamic modulation of Mcl‐1 protein expression imply their possible role in both cell differentiation and apoptotic response. Our results support the concept of modulation of NaBt effects by PUFAs, especially of ω–3 type, in colonic cells in vitro with diverse impact in cell lines derived from normal or neoplastic epithelium.
📜 SIMILAR VOLUMES
## Abstract Butyrate, a 4‐carbon fatty acid, has been shown to cause growth arrest and apoptosis of cancer cells __in vitro__ and __in vivo__. The signaling pathways leading to changes in cell growth are unclear. We used a functional proteomics approach to delineate the pathways and mediators invol
Butyrate is a potentially selective therapeutic agent for many adenocarcinomas. Butyrate causes reversible growth arrest as well as some death of VACO 5 colon cancer cells. Combined treatment with butyrate and the phorbol ester TPA leads instead only to cell death, while TPA causes little death on i